Vulcan’s $1B Raise Comes at a 34% Discount
Vulcan (ASX: VUL) announced today that it has completed its institutional placement at an offer price of A$4 per share. This represents a steep 34% discount to the last traded price of A$6.31 and a 21 percent discount to the theoretical ex-rights price of A$5.06. The institutional…
Step One Falls Flat
Step One (ASX: STP) experienced a heavy re-rating today, falling 35% in a single session. That is a substantial hit for any investor owning shares. The catalyst was the release of its H126 trading update, and the numbers came in well below expectations. Revenue is now forecast to land between A$30…
Argenica’s ARG-007 Clears the Way
Argenica Therapeutics (ASX: AGN) surged 22% today after confirming that its tenecteplase drug interaction study for ARG 007 met a key FDA requirement needed to lift the clinical hold on its US Investigational New Drug application. The study showed that ARG 007 does not interfere with the clot-dissolving activity of…
4DMedical Lands $15M Order from Philips, Marks Shift to Full Commercial Rollout
4DMedical (ASX:4DX) has taken a meaningful step forward, securing a US$10 million (~A$15 million) commercial order commitment from global imaging leader Philips.
With respiratory illness and chronic lung disease on the rise worldwide, healthcare systems are increasingly prioritising imaging solutions that are faster, safer,…
Gold Shines for Turaco
Turaco Gold (ASX: TCG) jumped 12% today after reporting strong gold intercepts from its Afema Gold Project in Côte d’Ivoire.
The Woulo Woulo infill drilling returned broad, consistent gold zones with grades up to 1.07 g/t gold, while the nearby Herman prospect delivered a higher-grade discovery, yielding surface-level gold at 32.6 g/t.
For…
Invion’s Global Photosoft Play Positions It as a Leader in PDT
Invion (ASX: IVX) surged 37% today after announcing it has secured perpetual, exclusive global rights to the Photosoft™ therapy platform, significantly expanding its patented pipeline across both human and animal health applications, including oncology, infectious diseases, and cardiovascular disorders.
Under the new agreement, Invion…
Major Capital Return and New Dividend Policy
QuickFee has distributed $28.5 million to shareholders as of 1 December, paid at 7.5 cents per share. The announcement sent the stock up 22% today as investors reacted positively to the capital return.
Following the distribution, the company’s pro forma balance sheet sits at around $11.2 million. QuickFee also…
Bitcoin’s Sharp Decline Rekindles the Debate Over Its True Value
Bitcoin remains a divisive topic among conservative investors, and its latest move only fuels the debate. The cryptocurrency fell 6.4% overnight, marking its largest single-day drop since March. The decline didn’t just hit digital assets, it also rippled through related equities. Companies like Robinhood, MicroStrategy,…
Titomic Proves Its Tech Can Take the Heat
Titomic (ASX: TTT) has faced a challenging few months, with shares falling nearly 50% from their yearly highs. However, the stock surged 12% today following a major technical milestone: the company successfully completed a hot-fire test on a solid rocket motor thrust chamber that was additively manufactured…
Montage Gold’s A$264m takeover ignites rally in African Gold
African Gold (ASX: A1G) has entered into a Scheme Implementation Deed with Montage Gold Corp, under which Montage will acquire African Gold in an all-scrip transaction. The announcement triggered a sharp 65% surge in African Gold’s share price.
Under the terms of the deal, African Gold shareholders…
